Shibata K, Makino I, Shibaguchi H, Niwa M, Katsuragi T, Furukawa T
School of Medicine, Fukuoka University, Japan.
Biochem Biophys Res Commun. 1997 Oct 20;239(2):633-7. doi: 10.1006/bbrc.1997.7521.
The present experiment demonstrates that the exposure of angiotensin II (AII) produced an up-regulation of the AT2 receptor mRNA level in rat cortical cells. AII (10(-9)-10(-5) M) exerted a marked increase of AT2 receptor mRNA in a dose-dependent manner. The maximum increase was observed at 3 hr of AII stimulation and lasted 3 hr. The up-regulation of AT2 receptor mRNA was antagonized by PD123319, an AT2 receptor antagonist, but not by SC-52458, an AT1 receptor antagonist, thus suggesting that the increase in AT2 receptor mRNA is mediated via AT2 receptor. This increase is blocked by serine/threonine phosphatase inhibitor okadaic acid, but not by the phosphotyrosine phosphatase inhibitor sodium vanadate, thus suggesting the involvement of serine/threonine phosphatase in this process. Protein kinase C inhibitor, H-7 and calphostin C, did not inhibit the AII-induced up-regulation significantly. In addition, calcium ionophore, A23187 had no effect. These findings suggest that the AT2 receptor mRNA expression by AII is regulated by the activity of serine/threonine phosphatase in the cortical neurons. This observation is also the first example concerning the regulation of AT2 receptor within the brain.
本实验表明,在大鼠皮质细胞中,血管紧张素II(AII)的暴露导致AT2受体mRNA水平上调。AII(10(-9)-10(-5) M)以剂量依赖性方式使AT2受体mRNA显著增加。在AII刺激3小时时观察到最大增加,并持续3小时。AT2受体mRNA的上调被AT2受体拮抗剂PD123319拮抗,但未被AT1受体拮抗剂SC-52458拮抗,因此表明AT2受体mRNA的增加是通过AT2受体介导的。这种增加被丝氨酸/苏氨酸磷酸酶抑制剂冈田酸阻断,但未被磷酸酪氨酸磷酸酶抑制剂钒酸钠阻断,因此表明丝氨酸/苏氨酸磷酸酶参与了这一过程。蛋白激酶C抑制剂H-7和钙泊三醇C并未显著抑制AII诱导的上调。此外,钙离子载体A23187没有作用。这些发现表明,AII对AT2受体mRNA表达的调节是由皮质神经元中丝氨酸/苏氨酸磷酸酶的活性介导的。这一观察结果也是关于脑内AT2受体调节的首个实例。